Loading provider…
Loading provider…
Internal Medicine Physician in San Francisco, CA
NPI: 1033176581Primary Practice Location
UCSF MEDICAL CENTER
1975 4th St, San Francisco, CA
Primary Employer
UCSF Medical Center
ucsfhealth.org
HQ Phone
Get MD Hope's Phone NumberMobile
Get MD Hope's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
1986 - 2026
CA State Medical License

American Board of Internal Medicine
Internal Medicine

American Board of Internal Medicine
Medical Oncology
Perelman School of Medicine - Philadelphia
med.upenn.edu
Medical School
Until 1984
UCSF School of Medicine
medschool.ucsf.edu
Fellowship • Hematology and Medical Oncology
1987 - 1990
Residency • Internal Medicine
1984 - 1987
Adaptive Randomization of Veliparib-Carboplatin Treatment in Breast Cancer.
Authors: William Symmans, Laura Esserman, Michael Hogarth, Tufia Haddad, Amy Chien, Donald Northfelt, Judy Boughey, Anne Wallace, Barbara Haley, Cheryl Ewing, Richard Schwab, Douglas Yee
Publication Date: 2016-07
Palbociclib and Letrozole in Advanced Breast Cancer
Authors: Dennis Slamon, Richard Finn
Journal: N Engl J Med
Lead Sponsor: Massachusetts General Hospital
Collaborators: Pfizer
Intervention / Treatment: DRUG: Talazoparib
Lead Sponsor: Laura Huppert, MD, BA
Collaborators: Gilead Sciences, Hoosier Cancer Research Network, Pfizer, Breast Cancer Research Foundation, Johns Hopkins University, Translational Breast Cancer Research Consortium, Array BioPharma
Intervention / Treatment: BIOLOGICAL: Anti-OX40 Antibody PF-04518600, DRUG: Avelumab, DRUG: Sacituzumab Govitecan, BIOLOGICAL: Utomilumab, DRUG: Liposomal Doxorubicin, DRUG: Binimetinib
Lead Sponsor: OBI Pharma, Inc
Intervention / Treatment: BIOLOGICAL: adagloxad simolenin combined with OBI-821, DEVICE: Globo H IHC Assay, OTHER: Standard of care treatment